is unlikely to misfold or aggregate in cells 12 . We hypothesized that some of the many BphP sequences in protein sequence databases might be monomeric in the ∆BphP form, which is likely to occur if the protein lacks strong hydrophobic interactions at the putative dimer interface. In contrast, in IFP1.4's parent, DrBphP 13 , the dimer interface includes several residues (Fig. 1a) : Leu311 appears to play a critical role, as the mutation L311K disrupts the dimer interface 3 . Analysis of ~40 BphP sequences from the NCBI database revealed BrBphP (from Bradyrhizobium) as a potential candidate, as the residue corresponding to Leu311 in DrBphP is a polar threonine (Fig. 1b) . Indeed, size-exclusion chromatography indicated that ∆BrBphP eluted later than dimeric ∆DrBphP and at a time similar to that of the monomeric form of IFP1.4 ( Supplementary Fig. 2 ), suggesting that ∆BrBphP is a monomer.
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We engineered the nonfluorescent ∆BrBphP into a fluorescent mutant. In brief, we selected several residues (Asp199, Tyr168, Val178 and Asn258) surrounding BV for saturation mutagenesis, which was followed by DNA shuffling 14 and random mutagenesis. The final fluorescent mutant mIFP absorbed maximally at 683 nm ( Supplementary Fig. 3) , with excitation and emission maxima of 683 and 704 nm, respectively (Fig. 1c) , a quantum yield of 8% and an extinction coefficient of 82,000 M −1 cm −1 (Supplementary Table 1 ). We confirmed that mIFP was monomeric at high concentrations (17 and 34 µM) ( Fig. 1d and Supplementary Fig. 4 ). Figs. 5 and 6 ), including 5 near the D-ring of BV that likely limit its rotation, contributing to the engineered fluorescence by increasing radiative decay of the excited state (Fig. 1e) . Mutated residues in mIFP, IFP1.4 and iRFP do not overlap and thus might be targeted for further engineering (Supplementary Fig. 7 ). mIFP was stable in pH 4-10 ( Fig. 1f) . Its molecular brightness was similar to that of IFP1. 4 Table 1) , and its cellular brightness was similar to that of iRFP and tenfold greater than that of IFP1.4 in live HeLa cells (Fig. 1g,h and Supplementary Fig. 8 ). mIFP was 6.3 times more photostable than IFP1.4 ( Supplementary Fig. 9 ) but approximately one-fifth as photostable as iRFP in HEK293 cells (Supplementary Table 1 ). Photobleaching of mIFP was irreversible ( Supplementary  Fig. 10 ), suggesting no residual photoisomerization. mIFP was similar to IFP2.0 and iRFP in terms of maturation rate, BV binding kinetics and affinity (Supplementary Figs. 11-13 ).
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To demonstrate mIFP as a protein tag for use in live-cell imaging, we constructed ~30 mIFP fusion proteins, targeting both the N and C termini with an appropriate-length linker (Online Methods). We successfully expressed and imaged the mIFP fusions in cultured cells without addition of the cofactor, which suggests that mIFP a naturally monomeric infrared fluorescent protein for protein labeling in vivo infrared fluorescent proteins (ifPs) provide an additional color to GfP and its homologs in protein labeling. drawing on structural analysis of the dimer interface, we identified a bacteriophytochrome in the sequence database that is monomeric in truncated form and engineered it into a naturally monomeric ifP (mifP). We demonstrate that mifP correctly labels proteins in live cells, Drosophila and zebrafish. it should be useful in molecular, cell and developmental biology.
GFP and its red homologs are powerful tools for cell and molecular biology 1, 2 . Recently, this fluorescent protein (FP) palette has been extended into the infrared region by introduction of bacteriophytochrome (BphP)-derived IFPs (for example, IFP1.4 and iRFP) that autocatalytically incorporate biliverdin (BV) as the chromophore [3] [4] [5] [6] [7] . As a protein fusion tag, an FP should be monomeric so as not to perturb the stoichiometry of the protein of interest. However, most BphPs function as multimeric complexes [8] [9] [10] ; both IFP1.4 and iRFP are derived from dimeric and truncated BphPs (∆BphP denotes truncations including only the PAS and GAF domains). Whereas iRFP is dimeric, in our previous characterization we reported IFP1.4 and its variant IFP2.0 (ref. 11) to be monomeric. However, we have found that IFP1.4 and IFP2.0 both tend to dimerize at high concentration, with dissociation constants of 7.8 µM and 3.7 µM, respectively ( Supplementary  Fig. 1 ). To develop a robust protein tag in the infrared spectrum, we decided to engineer a naturally monomeric IFP: mIFP.
We first identified a monomeric ∆BphP that, judging by the biological fitness of the bacteria expressing the full-length protein, used endogenous BV. These fusions localized properly in live cells (Supplementary Figs. 14-16 and Supplementary Videos 1-6), including those that require a high degree of monomeric character, such as α-tubulin, connexin 43 and intermediate filaments.
We observed all phases of mitosis in fusions of mIFP to human histones H1 and H2B. Additionally, mIFP was compatible with structured illumination microscopy ( Supplementary Fig. 17 ).
To demonstrate mIFP as a protein tag in live animals, we created histone fusions and imaged them in vivo in fruit flies and zebrafish. For the flies (Drosophila melanogaster), we created upstream activating sequence (UAS)-mIFP-histone 3.3 (H3.3) T2A heme oxygenase-1 (HO1) transgenic line and subsequently crossed it with the engrailed-GAL4 line to promote expression of mIFP-H3.3 in a segmental pattern. Here T2A is a 'self-cleaving' peptide widely used in coexpression of multiple genes 15 and HO1 converts heme to BV 16 . Coexpression of this enzyme was necessary to overcome the insufficient levels of endogenous BV in Drosophila. Confocal imaging of the embryo detected bright nuclear fluorescence with the expected segmental pattern (Fig. 2a,b) . For zebrafish (Danio rerio), we expressed mIFP-H2B with HO1 by mRNA injection at the one-cell stage. Imaging of the eye region at 30 hours post fertilization (h.p.f.) revealed bright nuclear fluorescence with the proper expression pattern (Fig. 2c) .
To apply mIFP in multicolor labeling in vivo, we coexpressed mIFP-H3.3 T2A HO1 and CD8-GFP in neurons of Drosophila. CD8 is a transmembrane protein that labels the cell membrane (as is CD4). We observed infrared fluorescence in the nucleus and green fluorescence in the cell membrane in the brain region of embryos, results suggesting correct targeting of the fusion proteins ( Fig. 2d-g ). We further expressed mIFP T2A HO1 in the abdominal muscle of Drosophila larvae, together with a GFP fusion trap of the extracellular matrix protein Viking (collagen) and CD4-tdTomato in class IV dendritic arborization (DA) neurons (ppkøCD4-tdTomato). Fluorescence imaging revealed separation of the three fluorophores ( Fig. 2h-j) and the expected structural organization of the labeled cell types (Fig. 2k) . Expression of CD4-mIFP T2A HO1 in class IV DA neurons in Drosophila larvae clearly and evenly labeled dendrites and axons (Fig. 2l,m) , as expected from previous results with CD4-GFP 17 .
To compare the naturally monomeric mIFP to our previously engineered monomeric IFP2.0 (which was derived from a dimeric parent), we expressed CD4-mIFP T2A HO1 and CD4-IFP2.0 T2A HO1 in epithelial cells of Drosophila larvae. Whereas mIFP-CD4 correctly labeled the epithelial cell membrane, IFP2.0-CD4 formed aggregates and failed to label the plasma membrane ( Supplementary Fig. 18a,b) . This is consistent with in vitro data showing that IFP2.0 tends to dimerize at high concentrations.
To demonstrate the use of mIFP in cell labeling, we expressed mIFP in different tissues and compared mIFP to engineered monomeric FPs derived from oligomeric parents, including the popular red FP mCherry, orange FP tdTomato 18 and red FP FusionRed 19 ( Supplementary Fig. 18 ). We found that mCherry formed punctate structures in the muscles and neurons of Drosophila first instar larvae. We observed these puncta in the body muscles of each of the more than 200 examined animals. Expression of FusionRed in the leg muscles of adult Drosophila revealed many rounded structures, which varied in diameter from 0.5 to 1.3 µm; tdTomato formed punctate structures with elongated shape varying in length from 2 to 6 µm with width of ~0.4 µm. In contrast, mIFP expression was homogeneous in all these contexts, similarly to what we observe with GFP ( Supplementary Fig. 19 ).
To examine potential toxicity of mIFP and HO1, we ubiquitously expressed them in Drosophila and conducted a viability assay. We did not find obvious toxicity differences between mIFP or mIFP T2A HO1 and GFP (Supplementary Fig. 20a ). Furthermore, we did not observe any defects in the eye morphogenesis of Drosophila ubiquitously expressing either mIFP or mIFP T2A HO1, and Drosophila embryos expressing mIFP-H3.3 T2A HO1 and CD8-GFP in neurons displayed normal ventral nerve cord shortening without any obvious differences with respect to embryos We note that coexpression with HO1 improved mIFP fluorescence by 30-to 40-fold in Drosophila muscle ( Supplementary  Fig. 20b,c) . We also observed no obvious toxicity in zebrafish expressing myristoylated mIFP (myr_mIFP) and HO1 by RNA injection at the one-cell stage, evaluated by comparison to zebrafish expressing only GFP (Supplementary Fig. 20d ).
To test whether coexpression of HO1 also improves iRFP fluorescence in zebrafish, we expressed myristoylated iRFP (myr_iRFP) with or without HO1 in the tail of embryo at 30 h.p.f. (Supplementary  Fig. 21 ). We observed little iRFP fluorescence in the absence of HO1. Coexpression of HO1 substantially increased iRFP fluorescence, which was obvious in the cell membrane in the tail. Zebrafish expressing myr_mIFP and HO1 showed similar levels of infrared fluorescence in the tail muscle ( Supplementary Fig. 21e,f) , a finding consistent with our in vitro data indicating that mIFP and iRFP have comparable BV binding kinetics and affinity.
In summary, we have engineered a naturally monomeric mIFP that requires biliverdin as a cofactor and have demonstrated its use for protein labeling in living cells and in vivo. mIFP is a good template for the development of infrared fluorescent reporters, such as for visualizing cell signaling in live animals. For example, we have designed and recently published an infrared fluorogenic protease reporter based on mIFP that visualizes apoptotic pathways in vivo 20 . Protein sequence databases contain thousands of BphPs. These proteins are promising starting points for rational design of future IFPs and related tools with desirable photophysical and photochemical properties. Protein purification and characterization. mIFP was expressed with a C-terminal polyhistidine tag in a pBAD expression vector (Invitrogen). Proteins were purified with the Ni-NTA purification system (Qiagen). Protein concentration was measured by the Pierce BCA method. Two different approaches were used to determine extinction coefficients. The first one was based on a comparison of absorbance values for the protein at the main peak (683 nm) with the absorbance value at the 391-nm peak, assuming the latter to have the extinction coefficient of the free BV, which is 39,900 M −1 cm −1 . The second one was based on direct measurement of the protein concentrations with a BCA protein assay kit (Pierce) followed by the calculation of extinction coefficient using a Beer-Lambert-Bouguer equation. For determination of quantum yield, mIFP solution was prepared with the same absorbance as a solution of Alexa Fluor 647 at wavelength 630 nm (quantum yield = 0.33 in phosphate-buffered saline (PBS)). The absorbance of both solutions is around or below 0.05. Fluorescence from 650 to 800 nm was collected and used to calculate the quantum yield. pH titrations were performed using a buffer series (100 mM sodium acetate, 300 mM NaCl for pH 2.5-5.0 and 100 mM NaH 2 PO 4 , 300 mM NaCl for pH 4.5-9.0).
To study protein maturation, we grew TOP10 bacterial cells at 37 °C overnight in a LB medium supplemented with ampicillin. The next morning, the cells were centrifuged, resuspended and cultured in LB medium with 0.002% arabinose, 0.001 mM IPTG, 100 µM ALA and 50 µM FeCl 3 for 1 h. The cells were washed and cultured in LB medium supplemented with 0.001 mM IPTG, 100 µM ALA and 50 µM FeCl 3 (no arabinose) at 37 °C. Fluorescence intensity of the cell suspension was measured every hour.
Gel-filtration chromatography was performed using a Superdex-200 HR 10/30 FPLC gel-filtration column (Amersham Biosciences). The column was equilibrated with sterile PBS in a cold room. 100 µl of purified protein at a concentration of 0.5 mg ml −1 in PBS were loaded in each column. Elution was performed in PBS at a flow rate of 0.5 ml min −1 for 45 min. The column effluent was monitored by absorbance at 280 and 630 nm. The gel-filtration protein standards thyroglobulin, BSA, azurin and aprotinin were also loaded under the same conditions to calibrate the column. The linear calibration curve representing the logarithm of molecular mass as a function of the fraction number was used to calculate the molecular mass of mIFP.
Analytical ultracentrifugation of mIFP, IFP1.4 and IFP2.0 was carried out by equilibrium sedimentation performed at 25 °C using a Beckman XL-I analytical ultracentrifuge. mIFP solutions were prepared at 34 µM and 17 µM, and IFP1.4 and IFP2.0 solutions were prepared at 17 µM and 8.5 µM, each in a buffer of 50 mM Tris, pH 7.5, 300 mM NaCl, 10 mM imidazole. Centrifugation was conducted at speeds of 25K, 30K, 35K and 40K r.p.m. with an An-60 Ti rotor (Fig. 1d) , and the radial gradient profiles were acquired by absorbance scans at 280 nm. Data were globally fitted to equilibrium sedimentation models of a single-species and/or monomer-dimer mixtures by a nonlinear least-squares method using Igor Pro (WaveMetrics).
Fusion plasmid construction. The mIFP mammalian expression vectors were constructed from C1 or N1 cloning vectors (Clontech-style). The mIFP cDNA was PCR amplified with a 5′ primer encoding an AgeI site and a 3′ primer encoding either a BspEI (C1) or NotI (N1) site, in reference to mIFP. To prepare the additional 14-amino-acid linker (GGGSGGGSGGGSSG) used for the C-terminal mIFP fusions, we used two primers: mIFP12-AgeI-C-f and mIFP12-BspEI-C-r (Supplementary Table 2 ). The PCR products were gel purified, digested and ligated into EGFP-C1 or EGFP-N1 cloning vectors, respectively, resulting in mIFP C1 and N1 cloning vectors.
To construct the mIFP C-terminal fusions (number of linker amino acids in parenthesis), we performed the following digests: DNA for transfection was prepared using the Plasmid Maxi kit (Qiagen).
In summary, the protein of interest can be fused to either the N or C terminus of mIFP. But it is necessary to note that in contrast to N-terminal mIFP fusions, C-terminal fusions often require an extended amino acid linker (see above). On the basis of the crystal structure of an mIFP homolog, the N terminus (first 17 amino acids) is unstructured and forms a flexible loop, whereas the C terminus is highly structured, forming an α-helix. Limited separation of mIFP and the protein of interest may cause steric hindrance. Inadequate C-terminal linker lengths result in erroneous localization and expression patterns characterized by faint membrane localization and decreased fluorescence. However, optimal linker length must still be determined experimentally.
Deposition of mIFP fusion plasmid. The mIFP fusions are available at Addgene. For each fusion, the N-or C-terminal fusion and the linker amino acid length are indicated after the name of the targeted proteins, followed by the Addgene plasmid number: mIFP-N1-54620; mIFP-Calnexin-N-14-56214; mIFP-Endo-14-56219; mIFP-Golgi-7-56221; mIFP-LaminA-C-18-56226; mIFP-Nup50-N-10-56233; mIFP-PMP-N-10-56238; mIFPTubulin-C-18-56240; mIFP-Actin-C-18-56211; mIFP-Cx26-7-56216; mIFP-H2B-6-56223; mIFP-Lysosomes-20-56228; mIFP-MapTau-N-10-56230; mIFP-Vimentin-7-56242; mIFP-C-Src-7-56213; mIFP-EB3-7-56218; mIFP-ER-5-56220; mIFP-Keratin-17-56225; mIFP-MyosinIIC-N-18-56232; mIFP-PMP-C-10-56237; mIFP-Annexin-12-56212; mIFP-CytERM-N-17-56217; mIFP-H2B-C-10-56224; mIFP-MANNII-N-10-56229; mIFP-Mito-7-56231; mIFP-PDHA1-N-10 -56236; mIFP-Zyxin-6-56243; mIFP-alpha-actinin-19-56210; mIFP-CENPB-N-22-56215; mIFP-H1-10-56222; mIFP-LC-myosin-N-7-56227; mIFP-Paxillin-22 -56234; mIFP-Tomm20-N-10-56239; mIFP-VASP-5-56241; mIFP12-C1-54819; mIFP12-Annexin-12-56245; mIFP12-LASP1-C-10-56257; mIFP12-Caveolin-C-10-56247; mIFP12-H2B-C-10-56254; mIFP12-MyosinIIa-C-18-56259; mIFP12-Rab4a-7-56261; mIFP12-Actin-C-18-56244; mIFP12-Clathrin-15-56249; mIFP12-LaminA-C-18-56256; mIFP12-CD81-10-56248; mIFP12-Endo-14-56250; mIFP12-ILK-C-14 -56255; mIFP12-sEspin-C-18-56262; mIFP12-CAF1-C-10-56246; mIFP12-FilaminA-C-14-56253; mIFP12-myopalladin-C-14-56258; mIFP12-myotilin-C-14-56260; mIFP12-ZO1-C-14-56265; mIFP12-Fibrillarin-7-56252; mIFP12-Farnesyl-5-56251; mIFP24-C1-54820; mIFP24-Caf1-C-10-56266; mIFP24-LaminA-C-18-56267. For studying the dependence of brightness of IFP-expressing cells on BV concentration, LN229 cells stably expressing mIFP, IFP1.4, IFP2.0 or iRFP (each coexpressed with GFP under IRES), grown on 60-mm dishes, were treated with various concentrations of BV for 2 h and collected by centrifugation. The IFP fluorescence was measured using the infinite M1000 plate reader (normalized by coexpressed GFP fluorescence) and was plotted against the BV concentration. s.d. was calculated from 3 independent measurements. To investigate BV binding kinetics, we treated live LN229 cells with 25 µM BV. The green and infrared fluorescence intensities were monitored using the infinite M1000 plate reader over time. The infrared fluorescence intensity (normalized by GFP) was plotted against time. s.d. was calculated from 3 independent measurements. To compare the brightness of IFPs in cells by flow cytometer, we transiently transfected live HeLa cells with IFP1.4 IRES EGFP, IFP2.0 IRES EGFP, mIFP IRES EGFP or iRFP IRES EGFP. 48 h after transfection, cells were washed and suspended in 0.5 ml PBS and analyzed on a flow cytometer (FACS Aria III). EGFP fluorescence was detected in the FITC-A channel (488-nm laser, 505-to 535-nm emission filter). IFP fluorescence was detected in the Alexa 700-A channel (640-nm laser, 708-to 753-nm emission filter). Data were processed using FlowJo software.
Structure illumination microscopy (SIM) was performed on a Zeiss Elyra PS.1 super-resolution imaging microscope. Fluorescence was excited using a 642-nm diode laser and 3-5 rotations of the grid pattern, filtered using a 655-nm long-pass filter, and collected using a Zeiss Plan-APOCHROMAT 100× (NA, 1.46) oil-immersion objective. All SIM image processing was performed using the proprietary ZEN 2012 Black software (Zeiss). 
